The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
"To promote the science and art of medicine and the betterment of public health." The A.M.A. has pursued its twin goals vigorously over these many years and has demonstrated a distinct and ...
BOSTON - About 75 North Atlantic right whales, representing about 20% of the critically endangered species' population worldwide, have gathered in an area off the coast of New England. A aerial ...
From 1971 to 1983, he lived in the west-end neighbourhood of Laurier Heights, shovelling walks for spending money, delivering the Edmonton Journal and graduating from St. Francis Xavier high ...
The plot centers on Bud and his steadfast wife Lollie, who, guided by the spirit of Buckminster Fuller, embark on a reflective journey through their past, confronting trauma and disappointment to find ...
After a search and seizure of her apartment, Rodriguez-Lopez was arrested by search warrant on Jan. 9 and charged with reckless endangerment and practicing medicine without a license. New Haven ...
A quantitative alcohol history should be recorded for all patients, because alcohol use contributes to many physical and mental disorders. A person-centered, nonjudgmental approach should be ...
People have been keeping personal diaries for several millenniums, but free smartphone apps now let you capture much more than words. By J. D. Biersdorfer J.D. Biersdorfer, the Tech Tip columnist ...
Panel A summarizes the conventional model of how oncogenic RAS guanosine triphosphatases (i.e., Kirsten rat sarcoma viral oncogene homologue [KRAS], neuroblastoma RAS viral oncogene homologue ...
with no new safety signals. Seven-year invasive disease–free survival was 80.8% with adjuvant T-DM1 and 67.1% with adjuvant trastuzumab, for an absolute difference of 13.7 percentage points.
A new morphometric fracture occurred in 22 women (6.3%) in the zoledronate–zoledronate group, in 23 women (6.6%) in the zoledronate–placebo group, and in 39 women (11.1%) in the placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results